Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48h of total sleep deprivation

被引:18
|
作者
Hansen, Devon A. [1 ,2 ]
Ramakrishnan, Sridhar [3 ]
Satterfield, Brieann C. [1 ,2 ,4 ]
Wesensten, Nancy J. [5 ]
Layton, Matthew E. [1 ,2 ]
Reifman, Jaques [3 ]
Van Dongen, Hans P. A. [1 ,2 ]
机构
[1] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA 99202 USA
[2] Washington State Univ, Elson S Floyd Coll Med, Spokane, WA 99202 USA
[3] US Army Med Res & Mat Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res, Frederick, MD USA
[4] Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ USA
[5] FAA, Air Traff Org, Washington, DC USA
关键词
Caffeine gum; Cognitive performance; Within-subject design; Dose response; Sleep loss; COGNITIVE PERFORMANCE; PSYCHOMOTOR VIGILANCE; MAINTAINS VIGILANCE; MODEL; FATIGUE; NIGHT; IMPAIRMENT; OPERATIONS; ALERTNESS;
D O I
10.1007/s00213-018-5140-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
RationaleCaffeine is widely used as a countermeasure against neurobehavioral impairment during sleep deprivation. However, little is known about the pharmacodynamic profile of caffeine administered repeatedly during total sleep deprivation.ObjectivesTo investigate the effects of repeated caffeine dosing on neurobehavioral performance during sleep deprivation, we conducted a laboratory-based, randomized, double-blind, placebo-controlled, crossover, multi-dose study of repeated caffeine administration during 48h of sleep deprivation. Twelve healthy adults (mean age 27.4years, six women) completed an 18-consecutive-day in-laboratory study consisting of three 48h total sleep deprivation periods separated by 3-day recovery periods. During each sleep deprivation period, subjects were awakened at 07:00 and administered caffeine gum (0, 200, or 300mg) at 6, 18, 30, and 42h of wakefulness. The Psychomotor Vigilance Test and Karolinska Sleepiness Scale were administered every 2h.ResultsThe 200 and 300mg doses of caffeine mitigated neurobehavioral impairment across the sleep deprivation period, approaching two-fold performance improvements relative to placebo immediately after the nighttime gum administrations. No substantive differences were noted between the 200 mgand 300mg caffeine doses, and adverse effects were minimal.ConclusionsThe neurobehavioral effects of repeated caffeine dosing during sleep deprivation were most evident during the circadian alertness trough (i.e., at night). The difference between the 200mg and 300mg doses, in terms of the mitigation of performance impairment, was small. Neither caffeine dose fully restored performance to well-rested levels. These findings inform the development of biomathematical models that more accurately account for the time of day and sleep pressure-dependent effects of caffeine on neurobehavioral performance during sleep loss.
引用
收藏
页码:1313 / 1322
页数:10
相关论文
共 50 条
  • [31] Effects of alcohol intoxication on driving performance, confidence in driving ability, and psychomotor function: a randomized, double-blind, placebo-controlled study
    Garrisson, Harriet
    Scholey, Andrew
    Verster, Joris C.
    Shiferaw, Brook
    Benson, Sarah
    PSYCHOPHARMACOLOGY, 2022, 239 (12) : 3893 - 3902
  • [32] Effects of Sodium Oxybate on Sleep Physiology and Sleep/Wake-related Symptoms in Patients with Fibromyalgia Syndrome: A Double-blind, Randomized, Placebo-controlled Study
    Moldofsky, Harvey
    Inhaber, Neil H.
    Guinta, Diane R.
    Alvarez-Horine, Sarah B.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (10) : 2156 - 2166
  • [33] Study protocol and rationale for a prospective, randomized, double-blind, placebo-controlled study to evaluate the effects of Ashwagandha (Withania somnifera) extract on nonrestorative sleep
    Deshpande, Abhijit
    Irani, Nushafreen
    Balakrishnan, Rathna
    MEDICINE, 2018, 97 (26)
  • [34] Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study
    Parekh, Rajesh
    Hammond, Billy R.
    Chandradhara, Divya
    ADVANCES IN THERAPY, 2024, 41 (04) : 1496 - 1511
  • [35] Chronic anemia and fatigue in elderly patients: Results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa
    Agnihotri, Parag
    Telfer, Margaret
    Butt, Zeeshan
    Jella, Abhay
    Cella, David
    Kozma, Chris M.
    Ahuja, Mukesh
    Riaz, Shahbaz
    Akamah, Joseph
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (10) : 1557 - 1565
  • [36] An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder
    Saligan, Leorey N.
    Luckenbaugh, David A.
    Slonena, Elizabeth E.
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 194 : 115 - 119
  • [37] Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study
    Rajesh Parekh
    Billy R. Hammond
    Divya Chandradhara
    Advances in Therapy, 2024, 41 : 1496 - 1511
  • [38] Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: A double-blind randomized crossover study
    Gill, M
    Haerich, P
    Westcott, K
    Godenick, KL
    Tucker, JA
    ACADEMIC EMERGENCY MEDICINE, 2006, 13 (02) : 158 - 165
  • [39] Effects of kivia powder on Gut health in patients with occasional constipation: a randomized, double-blind, placebo-controlled study
    Udani, Jay K.
    Bloom, David W.
    NUTRITION JOURNAL, 2013, 12
  • [40] Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance - Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase
    Ahmadpanah, Mohammad
    Pezeshki, Rana
    Soltanian, Ali Reza
    Jahangard, Leila
    Dursteler, Kenneth M.
    Keshavarzi, Amir
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 146 : 163 - 171